腹腔镜手术治疗肥胖症合并2型糖尿病现状及其进展
被引量:1
摘要
糖尿病是世界范围内严重的公共卫生问题,严重危害患者健康,消耗大量社会资源,一直是医学研究的重要方向。目前估计全球糖尿病患者超过1.7亿人次,且这个数字仍在增长,其中85%~90%为2型糖尿病患者,而90%的2型糖尿病患者合并肥胖或超重。肥胖症合并2型糖尿病传统上被视为内科疾病,治疗以调节饮食、运动、口服降糖药和注射胰岛素为主。这些方法在短期内可有一定疗效,但长期减肥和维持正常血糖的效果并不好。
出处
《中华腔镜外科杂志(电子版)》
2010年第5期54-57,共4页
Chinese Journal of Laparoscopic Surgery(Electronic Edition)
参考文献11
-
1Wei-Jei Lee,Weu Wang,Yi-Chih Lee,Ming-Te Huang,Kong-Han Ser,Jung-Chien Chen. Effect of Laparoscopic Mini-Gastric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI >35 and <35 kg/m2[J] 2008,Journal of Gastrointestinal Surgery(5):945~952
-
2Theodore K. Alexandrides,George Skroubis,Fotis Kalfarentzos MD, FACS. Resolution of Diabetes Mellitus and Metabolic Syndrome following Roux-en-Y Gastric Bypass and a Variant of Biliopancreatic Diversion in Patients with Morbid Obesity[J] 2007,Obesity Surgery(2):176~184
-
3Paolo Bernante MD,Mirto Foletto MD,Luca Busetto MD,Fabio Pomerri MD,Francesco Francini Pesenti MD,Maria Rosa Pelizzo MD,Donato Nitti MD. Feasibility of Laparoscopic Sleeve Gastrectomy as a Revision Procedure for Prior Laparoscopic Gastric Banding[J] 2006,Obesity Surgery(10):1327~1330
-
4Sotirios G Gabriel MD,Christos A Karaindros MD,Marianna A Papaioannou MD,Andreas A Tassioulis MD,Stratis G Gabriel MD,Vassilios I Sigalas MD,Panagiotis P Giannakakis MD. Biliopancreatic Diversion with Duodenal Switch Combined with Laparoscopic Adjustable Gastric Banding[J] 2005,Obesity Surgery(4):517~522
-
5E ETotté MD,L Hendrickx MD,M Pauwels MD,R Van Hee MD, PD. Weight Reduction by Means of Intragastric Device: Experience with the Bioenterics Intragastric Balloon[J] 2001,Obesity Surgery(4):519~523
-
6Robert Rutledge MD,FACS. The Mini-Gastric Bypass: Experience with the First 1,274 Cases[J] 2001,Obesity Surgery(3):276~280
-
7Edward E Mason MD,PhD. Ilial Transposition and Enteroglucagon/GLP-1 in Obesity (and Diabetic?) Surgery[J] 1999,Obesity Surgery(3):223~228
-
8P. Marceau,F.-S. Hould,S. Simard,S. Lebel,R.-A. Bourque,M. Potvin,S. Biron. Biliopancreatic Diversion with Duodenal Switch[J] 1998,World Journal of Surgery(9):947~954
-
9Douglas S Hess MD, FACS,Douglas W Hess MD. Biliopancreatic Diversion with a Duodenal Switch[J] 1998,Obesity Surgery(3):267~282
-
10M. Belachew,M. -J. Legrand,T. H. Defechereux,M. -P. Burtheret,N. Jacquet. Laparoscopic adjustable silicone gastric banding in the treatment of morbid obesity[J] 1994,Surgical Endoscopy(11):1354~1356
同被引文献9
-
1Wang Y,Xu A,Knight C,Xu LY,et al. Hydroxylation and glyeo- sylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insu- lin-sensitizing activity[J]. J Biol Chem,2002,277(22):19521.
-
2Fruebis J, Tsao TS,Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice[J], oe Natl Acad Sci U S A,2001,98(4);2005.
-
3Takahashi M,Arita Y, Yamagata K, et al. Genomic structure and mutations in adipose-specific gene,adiponectin[J]. Int J Obes Re- lat Metab Disord,2000,24(7) :861.
-
4Yang Q,Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes [J]. Nature,2005,436(7049) : 356.
-
5Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabete[J]. Nature,2005,436(7049) :356.
-
6Lewis JG,Shand gI,Elder PA,et al. Plasma retinol-binding pro- tein is unlikely to be a useful marker of insulin resistance[J].Di- abetes Res Clin Pract, 2008,80(1) :e13.
-
7周强,吴晓蔓.脂联素与肥胖症、胰岛素抵抗及2型糖尿病[J].国际检验医学杂志,2008,29(10):899-900. 被引量:7
-
8吴丹冬,任伟.视黄醇结合蛋白4与胰岛素抵抗[J].国际内科学杂志,2009,36(12):697-700. 被引量:1
-
9孙霞,汪大望,武蓉珍,徐海燕,夏苏娇,陈凯,徐爱花,毛皓愉.内脏脂肪素、脂联素、瘦素与肥胖、2型糖尿病的相关性研究[J].中国糖尿病杂志,2010,18(12):883-885. 被引量:7
二级引证文献7
-
1戚仁娟,胡红琳,夏莉,刘炯炯,王长江,方朝晖.西格列汀对2型糖尿病鼠血清及不同组织视黄醇结合蛋白4的影响[J].安徽医学,2015,36(4):387-390. 被引量:3
-
2姚建平,李顺斌,郑淑莺,邱蔚.视黄醇结合蛋白4与糖尿病视网膜病变的相关性研究[J].浙江医学,2015,37(12):1058-1060. 被引量:2
-
3周宗爱,汤智越,王新红.新诊断2型糖尿病老年患者血清脂联素、视黄醇结合蛋白4水平与代谢综合征的关系研究[J].中国医师杂志,2015,17(6):946-947. 被引量:3
-
4王燕,赵莹.肥胖及非肥胖2型糖尿病使用瑞格列奈治疗的对比分析[J].中国医药指南,2016,14(24):37-38. 被引量:6
-
5马玉梅,朱滢.T2DM患者胰岛β细胞功能衰竭所致血清APN及抵抗素变化的意义[J].中国临床实用医学,2016,7(5):76-77. 被引量:1
-
6俞善春,葛冰磊.血清Chemerin、CTRP3、RBP4在肥胖2型糖尿病患者中的变化及意义[J].国际检验医学杂志,2018,39(15):1805-1808. 被引量:5
-
7黎清现,熊祖员,许锦富.2型糖尿病并发不同程度肾病患者血清APN和VEGF表达与氧化应激的相关性[J].中国老年学杂志,2015,35(10):2692-2694. 被引量:7
-
1董毅.秋冬护心,学吃“兔子食”[J].中国家庭医生,2016,0(23):22-22.
-
2姜蕾.快乐降糖,走出饮食误区[J].健康生活,2013(1):47-47.
-
3于天良.糖尿病诊断中糖化血红蛋白检测的意义[J].中国社区医师(医学专业),2010,12(4):105-105. 被引量:1
-
4庄玉春,王明明,于爱华.高血压患者的饮食及用药指导[J].中国医药指南,2010,8(25):160-161. 被引量:9
-
5吴金义,张木兰,王凌燕,孟繁波,孙晓丽.胰岛素抵抗与冠心病关系探讨[J].白求恩医科大学学报,1995,21(4):393-395. 被引量:2
-
6姜蕾,常怡勇.快乐降糖,走出饮食误区[J].糖尿病新世界,2012(1):32-33.
-
7杨晓燕,沈杰.类风湿关节炎相关间质性肺疾病的诊治研究进展[J].中国中医急症,2016,25(1):102-105. 被引量:11
-
8南海燕,陈静,孙颖,宋静,黄祎玮.糖尿病肾病治疗的研究进展[J].临床合理用药杂志,2014,7(13):198-199. 被引量:4
-
9雍伟哲.《中国成人血脂异常防治指南(2016年修订版)》发布[J].中华医学信息导报,2016,0(20):5-5. 被引量:2
-
10柯元南.高血压问答——治疗篇[J].中老年保健,2015,0(3):18-19.